Milestone Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell MIST and other ETFs, options, and stocks.

About MIST

Milestone Pharmaceuticals, Inc. engages in the development and commercialization of cardiovascular medicines. Its lead product candidate etripamil, is a novel, potent and short-acting calcium channel blocker that is designed as a rapid-onset nasal spray to be self-administered by patients. 

CEO
Joseph G. Oliveto
CEOJoseph G. Oliveto
Employees
38
Employees38
Headquarters
Montréal, Québec
HeadquartersMontréal, Québec
Founded
2003
Founded2003
Employees
38
Employees38

MIST Key Statistics

Market cap
100.23M
Market cap100.23M
Price-Earnings ratio
-1.14
Price-Earnings ratio-1.14
Dividend yield
—
Dividend yield—
Average volume
1.52M
Average volume1.52M
High today
$0.8199
High today$0.8199
Low today
$0.78
Low today$0.78
Open price
$0.7809
Open price$0.7809
Volume
321.23K
Volume321.23K
52 Week high
$3.06
52 Week high$3.06
52 Week low
$0.7521
52 Week low$0.7521

Stock Snapshot

The current Milestone Pharmaceuticals(MIST) stock price is $0.80, with a market capitalization of 100.23M. The stock trades at a price-to-earnings (P/E) ratio of -1.14.

As of 2026-09-28, Milestone Pharmaceuticals(MIST) stock has fluctuated between $0.78 and $0.82. The current price stands at $0.80, placing the stock +2.6% above today's low and -2.4% off the high.

Milestone Pharmaceuticals(MIST) shares are trading with a volume of 321.23K, against a daily average of 1.52M.

In the last year, Milestone Pharmaceuticals(MIST) shares hit a 52-week high of $3.06 and a 52-week low of $0.75.

In the last year, Milestone Pharmaceuticals(MIST) shares hit a 52-week high of $3.06 and a 52-week low of $0.75.

MIST News

Investing.com 4d
Montreal Heart Institute enrolls first Canadian patient in AFib trial - Investing.com

...

Montreal Heart Institute enrolls first Canadian patient in AFib trial - Investing.com

Analyst ratings

86%

of 7 ratings
Buy
85.7%
Hold
14.3%
Sell
0%

People also own

Based on the portfolios of people who own MIST. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.